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http://dx.doi.org/10.1016/j.jmii.2013Background/Purpose: The clinical aspects of virulence genes of uropathogenic Escherichia coli
(UPEC) are not fully understood. This study compared the presence of virulence genes in UPEC
isolated from urinary tract infections (UTIs) and asymptomatic bacteriuria (ABU) in children.
Methods: The study included children with UTI (nZ 15) or ABU (nZ 49) treated at Chung-Ang
University Yongsan Hospital between 2010 and 2011. The strains were acquired from each urine
sample collected, and 18 major virulence genes were detected by polymerase chain reaction.
Antimicrobial susceptibility of all UPEC isolates was determined.
Results: Sixty-four E. coli strains were isolated from the urine samples. The most commonly
identified virulence gene in both groups was fimH (100.0% in the UTI group and 95.9% in the
ABU group). The UTI isolates showed a higher prevalence of papEF and fyuA, and a lower prev-
alence of feoB than ABU isolates (p < 0.01 for all). The profile of virulence gene,
fimHþkpsMTIIþfeoBþ also showed a significant difference between the two groups
(p < 0.01). Isolates from ABU were more resistant to most antimicrobials tested. The presence
of papEF, feoB, and fyuA also correlated with the antimicrobial susceptibility of UPEC.
Conclusion: The virulence gene repertoire was different in the UPEC of UTI and ABU. The pa-
pEF, feoB, and fyuA genes showed meaningful differences between the two groups and may
have an important role in the pathogenesis of overt UTI.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.of Pediatrics, Chung-Ang University Medical Center, Heukseok-dong, Dongjak-gu, Seoul, South Korea.
m (I.S. Lim).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
.07.010
456 K.W. Yun et al.Introduction Detection of virulence genesUrinary tract infection (UTI) refers to an infection with
microbial pathogens at any site in the urinary tract, which
includes the urethra, bladder, ureter, and kidneys. UTI is
the most common bacterial infection in children; many
affected children, particularly infants, have severe symp-
toms and lobar nephronia. Kidney scarring related to UTI
has been linked to long-term morbidity.1,2 By contrast,
asymptomatic bacteriuria (ABU) is a condition in which
bacteria subclinically colonize the urinary tract, closely
resembling commensalism at other mucosal sites. ABU
strains are well adapted for growth in the human urinary
tract, without causing any clinical symptoms. Therefore,
ABU strains are an interesting model for the study of
mechanisms of commensalism and the driving forces be-
tween the pathogen and the host.3,4
Uropathogenic Escherichia coli (UPEC) are the most
common bacterial pathogens that cause UTI and ABU in
children. Extended-spectrum beta-lactamases-producing
UPEC strains, which are increasing in prevalence world-
wide, have an appreciable deleterious impact on the clin-
ical management of UTI.5,6 The UPEC strains harbor many
genes that encode various virulence factors, which
contribute to enhanced pathogenicity. The molecular
characteristics and functions of these virulence genes have
been well established.7e12 The severity of UTI reflects the
virulence profile or phenotype of the infecting strain, with
many virulence factors being expressed fully at a higher
frequency by strains causing UTI than by strains causing
ABU.13e15
In this study, we sought to identify the prevalence and
expression patterns of virulence genes in UPEC isolated
from children in South Korea. We also compared the viru-
lence gene repertoire in UPEC strains isolated from UTIs
and ABU, with the aim of clarifying important virulence
factors for the development of clinical diseases of the uri-
nary tract in children.Materials and methods
Participants
This study was performed at Chung-Ang University Yongsan
Hospital between March 2010 and February 2011. All par-
ticipants were children <18 years of age who lived in
Seoul, Korea, during the study period. Inclusion criteria
were fever with an axillary temperature of 38C, positive
urine culture (>105 colony-forming units/mL), and pyuria
(>5 white blood cells/high-power field). Children who did
not have any urinary symptoms (i.e., urgency, frequency,
and dysuria) but had significant growth of E. coli (>105
colony-forming units/mL) were considered to have ABU.
The urine samples were collected through midstream urine
in toilet-trained children and by a sterile urine-collecting
bag in others. The study protocol was reviewed and
approved by the Institutional Review Board (No. 10-013-02-
03) at Chung-Ang University Hospital, and written informed
consent was obtained from the parents/guardians of all
participants.All E. coli isolates were identified by typical morphology,
lactose fermentation, positive spot indole test, and VITEK 2-
GN card (bioMe´rieux, Hazelwood, MO, USA). Only one isolate
per patient was examined. Extraction and purification of
DNA from all UPEC isolates were performed as described in
the QIAamp Kit (Qiagen GmbH, Hilden, Germany). The
presence of the following virulence genes was assessed by
18 simplex polymerase chain reaction (PCR):adhesion pro-
teins (papA, papC, papEF, papGI, papGII, papGIII, sfa, fimH,
afa, bmaE ), toxins (hlyA, cdtB), siderophores (fyuA, iutA,
feoB), capsule synthesis proteins (kpsMTII, kpsMTIII ), and
uropathogenic-specific protein (usp). Primer sequences for
amplification of these individual virulence genes have been
published in previous studies16e19 and are listed in Table 1.
PCR was consistently performed in a 20-mL reaction volume,
with each reaction mixture containing 1.0 mL of DNA tem-
plate, 10 mM of each primer, 2.0 mL of 10 Taq buffer,
2.5 mM of deoxynucleotide triphosphates, and 2.5 mM of
Taq polymerase (iNtRON, Seoul, Korea). Thermal cycling
was performed in a PTC-200 Peltier thermal cycler DNA
engine (MJ Research, Watertown, MA, USA) under the
following conditions: denaturation for 5 minutes at 94C; 35
1-minute amplification cycles at 94C, and additional
amplification cycles for 1 minute at 55C, 2 minutes at 72C,
and a final extension cycle for 10 minutes at 72C. The PCR
products were electrophoresed on agarose gels, stained
with ethidium bromide, and photographed using a UV
transillumination imaging system.
Antimicrobial susceptibility test
Antimicrobial susceptibility testing of all isolates to ampi-
cillin, gentamicin, piperacillin, trimethoprim/sulfamethox-
azole, tetracycline, amoxicillin/clavulanic acid, cefazolin,
aztreonam, ciprofloxacin, cefepime, cefotaxime, tobramy-
cin, piperacillin/tazobactam, and levofloxacin was per-
formed using the VITEK 2 automated system (bioMe´rieux). In
addition, in vitro antimicrobial susceptibility testing was
performed by the brothmicrodilutionmethod and the results
were interpreted using the 2010 Clinical and Laboratory
Standards Institute breakpoints.
Statistical analyses
All statistical analyses were performed using SPSS version
18.0 (SPSS, Chicago, IL, USA). The prevalence of virulence
genes and antibiotic resistance patterns were compared
between the two groups using Pearson Chi-square test and
Fisher exact test. Continuous variables were compared with
the Student t test and ManneWhitney U test. A p value
<0.05 was considered statistically significant.
Results
Clinical characteristics
A total of 64 patients were included in this study, of which 15
were diagnosed with UTI and 49 with ABU. In patients with
Table 1 Sequence of primers used in polymerase chain reaction for virulence genes
Gene Primer sequence (50e30) Size of product (bp) Primer coordinates Source of primer
papA F: ATGGCAGTGGTGTTTTGGTG
R: CGTCCCACCATACGTGCTCTTC
720 1796e1817
2495e2516
16
papC F: GTGGCAGTATGAGTAATGACCGTTA
R: ATATCCTTTCTGCAGGGATGCAATA
200 4774e4798
4952e4976
16
17
papE/F F: GCAACAGCAACGCTGGTTGCATCAT
R: AGAGAGAGCCACTCTTATACGGACA
336 8025e8049
8336e8360
17
papGI F: TCGTGCTCAGGTCCGGAATTT
R: TGGCATCCCCCAACATTATCG
461 8871e8891
9311e9331
17
papGII F: GGGATGAGCGGGCCTTTGAT
R: CGGGCCCCCAAGTAACTCG
190 1604e1623
1775e1793
17
papGIII F: GGCCTGCAATGGATTTACCTGG
R: CCACCAAATGACCATGCCAGAC
258 1420e1441
1656e1677
17
sfa/foc F: CTCCGGAGAACTGGGTGCATCTTAC
R: CGGAGGAGTAATTACAAACCTGGCA
410 NA 17
fimH F: TGCAGAACGGATAAGCCGTGG
R: GCAGTCACCTGCCCTCCGGTA
508 1814e1839
2256e2278
16
Afa F: GGCAGAGGGCCGGCAACAGGC
R: CCCGTAACGCGCCAGCATCTC
559 4589e4609
5160e5180
16
bmaE F: ATGGCGCTAACTTGCCATGCTG
R: AGGGGGACATATAGCCCCCTTC
507 79e100
562e583
16
hlyA F: AACAAGGATAAGCACTGTTCTGGCT
R: ACCATATAAGCGGTCATTCCCGTCA
1177 2420e2449
3572e3596
17
cdtB F: AAATCACCAAGAATCATCCAGTTA
R: AAATCTCCTGCAATCATCCAGTTTA
430 1735e1758
1463e1485
16
iutA F: GGCTGGACATCATGGGAACTGG
R: CGTCGGGAACGGGTAGAATCG
300 851e872
1132e1152
17
feoB F: AATTGGCGTGCATGAAGATAACTG
R: AGCTGGCGACCTGATAGAACAATG
470 NA 17
fyuA F: TGATTAACCCCGCGACGGGAA
R: CGCAGTAGGCACGATGTTGTA
880 775e795
1539e1559
16
18
kpsMTII F: GCGCATTTGCTGATACTGTTG
R: CATCCAGACGATAAGCATGAGCA
272 297e317
544e566
16
kpsMTIII F: TCCTCTTGCTATTATTCCCCCT
R: AGGCGTATCCATCCCTCCTAAC
392 4050e4071
4418e4439
16
Usp F: ATGCTACTGTTTCCGGGTAGTGTGT
R: CATCATGTAGTCGGGGCGTAACAAT
1000 NA 19
bp Z base pairs; F Z forward; NA Z not available; R Z reverse.
Virulence factors of UPEC in UTI and ABU 457ABU, 21 were healthy children and 28 were children with
other diseases; upper respiratory tract infection (n Z 9),
bronchiolitis (n Z 8), functional gastrointestinal disorder
(nZ 5), and acute gastroenteritis (nZ 6). Each UTI and ABU
group contained both outpatients and inpatients. The me-
dian age was 7.5months (range: 1.6e98.8 months) in the UTI
group and 15.4months (range: 0.5e167.9months) in the ABU
group (Table 2). The ratio of males to females was 2:1 in the
UTI group and 1.7:1 in the ABU group. There were no statis-
tically significant differences in age and sex of participants
(p >0.05, respectively). By contrast, higher levels of C-
reactive protein, increased erythrocyte sedimentation rate,
and a proportion of neutrophil were identified among pa-
tients diagnosed with UTI (p <0.05, for all).
Virulence gene repertoire in UPEC
Eighteen virulence genes were explored to determine the
virulence repertoire in the UPEC isolates. The frequentlyidentified virulence genes were fimH (n Z 62, 96.9%),
kpsMTII (n Z 54, 84.4%), feoB (n Z 43, 67.2%), iutA
(n Z 34, 53.1%), fyuA (n Z 29, 45.3%), and papA (n Z 29,
45.3%). The papGI, cdtB, and kpsMTIII genes were not
detected (Table 3). Isolates from the ABU group expressed
fewer virulence factors than those from the UTI group
(4.98  1.81 vs. 5.93  1.44, respectively, p < 0.05, data
not shown). The prevalence of virulence genes in patients
over 6 months of age did not differ from those in patients
<6 months of age (p >0.05, data not shown). The compo-
nents of the virulence genes were similar in both sexes,
except for papEF, which was found more frequently in fe-
males than in males (p <0.05, data not shown).
In patients with UTI and ABU, the virulence gene most
frequently detected was fimH (UTI group: n Z 15, 100.0%;
ABU group: n Z 47, 95.9%). In the UTI group, kpsMTII
(nZ 14, 93.3%), fyuA (nZ 12, 80.0%), iutA (nZ 9, 60.0%),
and papA (n Z 9, 60.0%) were commonly identified in that
order. The detected genes in the ABU group, in descending
Table 2 Patient characteristics of the urinary tract
infection and asymptomatic bacteriuria groups
UTI group
(n Z 15)
ABU group
(n Z 49)
p
Median age (mo) 7.5 15.4 0.117
Male:female 2:1 1.7:1 0.810
WBC (/mm3) 13,732  7448 10,384  4304 0.076
Neutrophil (%) 55  22 41  19 0.013*
CRP (mg/dL) 4  4.2 0.5  0.6 0.001**
ESR (mm) 30.8  25.9 17.2  18.5 0.027*
BUN (mg/dL) 8.5  4.1 9.7  4.4 0.326
Creatinine (mg/dL) 0.5  0.1 0.4  0.1 0.093
*p < 0.05.
**p < 0.01.
ABU Z asymptomatic bacteriuria; BUN Z blood urea nitrogen;
CRP Z C-reactive protein; ESR Z erythrocyte sedimentation
rate; UTI Z urinary tract infection; WBC Z white blood cell.
458 K.W. Yun et al.order of prevalence, were feoB (n Z 40, 81.6%), kpsMTII
(n Z 40, 81.6%), iutA (n Z 25, 51.0%), and papA (n Z 20,
40.8%). Only three virulence genes showed a meaningful
difference of distribution between the groups; UTI isolates
showed a higher prevalence of papEF and fyuA, and a lowerTable 3 Prevalence of virulence factors detected and its select
bacteriuria groups
Function Virulence genes Total (n Z 6
Adhesion afa 9.4 (6)
bmaE 1.6 (1)
fimH 96.9 (62)
papA 45.3 (29)
papC 3.1 (2)
papEF 17.2 (11)
papGI 0.0 (0)
papGII 28.1 (18)
papGIII 10.9 (7)
sfa/foc 15.6 (10)
Toxins cdtB 0.0 (0)
hlyA 20.3 (13)
Siderophores feoB 67.2 (43)
fyuA 45.3 (29)
iutA 53.1 (34)
Capsule synthesis kpsMTII 84.4 (54)
kpsMTIII 0.0 (0)
Uropathogen
specific
usp 21.9 (14)
Profiles of
virulence
genes
fimHþkpsMTIIþiutAþ 43.8 (28)
fimHþkpsMTIIþpapAþ 42.2 (27)
fimHþkpsMTIIþfeoBþ 56.3 (36)
fimHþkpsMTIIþiutAþpapAþ 25.0 (16)
fimHþkpsMTIIþiutAþfeoBþ 25.0 (16)
fimHþkpsMTIIþpapAþfeoBþ 25.0 (16)
fimHþkpsMTIIþpapAþiutAþfeoBþ 12.5 (8)
*p < 0.01.
ABU Z asymptomatic bacteriuria; NA Z not available; UTI Z urinaryprevalence of feoB than ABU isolates (p <0.01 for all, Table
3). There were no significant differences in the number of
detected virulence genes according to sex and age group
(<6 months vs. 6 months of age) in the UTI and ABU
groups (data not shown).
Prevalence of the specific profiles of virulence genes was
analyzed. On the basis of fimH and kpsMTII, we considered
the combinations of three common virulence genes,
namely, iutA, feoB, and papA. The virulence profiles
fimHþkpsMTIIþiutAþ and fimHþkpsMTIIþpapAþ (n Z 8,
53.3%, in both) were most common in the UTI group and
fimHþkpsMTIIþfeoBþ (n Z 33, 67.3%) was most common in
the ABU group. There was a significant difference between
the two groups concerning the prevalence of the
fimHþkpsMTIIþfeoBþ profile (20.0% in the UTI group vs.
67.3% in the ABU group; p <0.01, Table 3).
Antimicrobial susceptibility
Antimicrobial susceptibility patterns were different ac-
cording to the origin of UPEC. Isolates from ABU were more
resistant to all tested antimicrobials, except cefazolin and
tetracycline. Among them isolates of ABU were significantly
more resistant to piperacillin and cefotaxime than UTI (67%
vs. 27%; 100% vs. 74%, p <0.05, respectively, Table 4).
However, there were no significant differences ined profiles from the urinary tract infection and asymptomatic
4), % (n) UTI (n Z 15), % (n) ABU (n Z 49), % (n) p
13.3 (2) 8.2 (4) 0.618
6.7 (1) 0.0 (0) 0.234
100.0 (15) 95.9 (47) > 0.99
60.0 (9) 40.8 (20) 0.192
0.0 (0) 4.1 (2) > 0.99
46.7 (7) 8.2 (4) 0.002*
0.0 (0) 0.0 (0) NA
46.7 (7) 22.4 (11) 0.068
6.7 (1) 12.2 (6) > 0.99
13.3 (2) 16.3 (8) > 0.99
0.0 (0) 0.0 (0) NA
20.0 (3) 20.4 (10) > 0.99
20.0 (3) 81.6 (40) < 0.001*
80.0 (12) 34.7 (17) 0.003*
60.0 (9) 51.0 (25) 0.542
93.3 (14) 81.6 (40) 0.429
0.0 (0) 0.0 (0) NA
26.7 (4) 20.4 (10) 0.723
53.3 (8) 40.8 (20) 0.393
53.3 (8) 38.8 (19) 0.318
20.0 (3) 67.3 (33) 0.002*
26.7 (4) 24.5 (12) > 0.99
6.7 (1) 30.6 (15) 0.089
6.7 (1) 30.6 (15) 0.089
0.0 (0) 16.3 (8) 0.181
tract infection.
Figure 1. Relationship between virulence factors and anti-
microbial susceptibility: (A) tetracycline susceptibility was
related to the prevalence of papEF and fyuA genes. (B) Strains
with feoB gene were exclusively susceptible to tetracycline
and cefazolin, but more resistant to cefotaxime. *p < 0.05.
Virulence factors of UPEC in UTI and ABU 459antimicrobial susceptibility according to sex and age group
(<6 months vs. 6 months of age) in the UTI and ABU
groups (data not shown).
By contrast, there was no relationship between the
presence of virulence genes and antimicrobial susceptibil-
ity of UPEC, except for papEF, feoB, and fyuA. The papEF
and fyuA genes were more prevalent in tetracycline-
resistant isolates than tetracycline-susceptible isolates
(60% vs. 14%; 100% vs. 41%, p <0.05, respectively, Fig. 1A).
However, feoB was exclusively identified in tetracycline-
and cefazolin-susceptible isolates, and was more
frequently identified in cefotaxime-resistant isolates than
susceptible isolates (92% vs. 61%, p <0.05, Fig. 1B).
Discussion
ABU is a condition closely resembling bacterial commen-
salism at the mucosa of urinary tract, but is also considered
as the most common form or risk factor of symptomatic
UTI.3,20e22 A recent study revealed that ABU might protect
against symptomatic recurrence of UTI in young women.23
The UPEC strains causing ABU may outcompete strains
causing UTI in the urinary tract of humans.24 These char-
acteristics of ABU differentiate the virulence of the bac-
terial strains causing ABU from those causing UTI. The ABU
strains reportedly express fewer virulence factors or harbor
attenuated virulence genes than strains causing symptom-
atic UTI.13e15 However, these studies were mostly per-
formed in adults rather than in children, particularly
infants, having more severe symptoms and complications.
In the present study, we reported that ABU strains alsoTable 4 Antimicrobial resistance of uropathogenic
Escherichia coli isolated from the urinary tract infection
and asymptomatic bacteriuria groups
Antimicrobials Resistance, % (n) p
UTI (n Z 15) ABU (n Z 49)
Ampicillin 53.3 (8) 75.5 (37) 0.100
Amoxicillin/
clavulanate
6.7 (1) 26.5 (13) 0.157
Piperacillin 33.3 (5) 73.5 (36) 0.012*
Piperacillin/
tazobactam
0.0 (0) 14.3 (7) 0.185
Cefazolin 6.7 (1) 4.1 (2) 0.558
Cefotaxime 0.0 (0) 26.5 (13) 0.028*
Ceftriaxone 0.0 (0) 20.4 (10) 0.100
Cefepime 0.0 (0) 20.4 (10) 0.100
Aztreonam 0.0 (0) 20.4 (10) 0.100
Gentamicin 26.7 (4) 40.8 (20) 0.313
Tobramycin 0.0 (0) 12.2 (6) 0.322
Tetracycline 13.3 (2) 6.1 (3) 0.583
Trimethoprim/
sulfamethoxazole
20.0 (3) 46.9 (23) 0.078
Ciprofloxacin 0.0 (0) 4.1 (2) > 0.99
Levofloxacin 0.0 (0) 8.2 (4) 0.565
*p < 0.05.
ABU Z asymptomatic bacteriuria; UTI Z urinary tract infec-
tion.expressed fewer virulence factors than UTI strains in
children.
Virulence factors of UPEC are associated with coloniza-
tion and survival in the normal urinary tract, and influence
the pathogenicity of symptomatic or complicated
UTIs.9,25e27 These virulence factors are adhesion proteins
(e.g., P fimbriae, S and F1C fimbriae, and type 1 fimbriae),
iron-acquisition systems (e.g., aerobactin), toxins (e.g.,
hemolysin), and host defense-avoidance mechanisms (e.g.,
capsule or O-specific antigen).28 Bacterial adherence to
urinary epithelia is a crucial step in the development of
UTI, allowing the bacteria to persist in the urinary tract
against flushing by urine flow and activation of host
signaling pathways.11,29 In mammalian hosts, free iron
concentrations are very low for the growth of pathogenic
bacteria. Thus, many bacteria, including UPEC, have mul-
tiple ways of getting iron from the host through the
expression of iron-acquisition systems.30 The utilization of
various toxins secreted by UPEC strains is well recognized.
Among these toxins, a-hemolysin encoded by hlyA is an
extracellular cytolytic protein toxin that is produced by up
to 50% of UPEC isolates. a-Hemolysin has been associated
with clinical severity in UTI patients.31 In our study, hlyA
was detected in 20.0% of UTI strains and in 20.4% of ABU
strains.
In this study, the fimH adhesion gene was the most
common virulence gene in both UTI and ABU isolates (fre-
quencies of 100% and 96%, respectively). Previous studies
460 K.W. Yun et al.have established that fimH is most frequent in isolates from
a variety of forms of UTI.15,32e34 The pap gene family of
adherence virulence genes (papA, papC, papEF, papGII, and
papGIII in this study), which are expressed as P fimbriae,
was also prevalent in the UTI and ABU isolates. Among the
pap genes, papA was the second most prevalent adhesion
gene in the UTI group (60.0%, nZ 9) and ABU group (40.8%,
n Z 49). Furthermore, papEF was more frequently identi-
fied in the UTI group than in the ABU group (46.7% vs. 8.2%,
respectively, p < 0.05). In some UPEC strains, it is
conceivable that papEF is active in the progression to
symptomatic UTI from ABU. One study described the pres-
ence of papEF in over half of the isolates obtained from
severe invasive urinary tract diseases.33
The third most common gene in the UTI isolates was
fyuA (n Z 12, 80.0%), which is one of the bacterial iron-
acquisition systems. However, ABU isolates showed a
much lower prevalence of fyuA (n Z 17, 34.7%, p <0.01).
The finding supports the importance of fyuA in virulence,
particularly in the establishment of symptomatic UTI. The
relationship between fyuA and invasive UTI had been sus-
pected in previous studies.16,18,33 By contrast, a recent
study reported that feoB and fimH were the most prevalent
virulence genes of UPEC isolated from patients with
community-acquired UTI in China.34 In the present study,
the prevalence of feoB in UTI isolates was much lower
(20.0%) than those (>92%) reported in China. By contrast,
feoB was identified in ABU strains at a higher frequency
(81.6%) in our isolates. These discrepancies might be due to
the difference in epidemiology of strains or lower UTI
sample size in this study. The feoB gene might have a role in
iron acquisition in both UTI and ABU, although it is unclear
whether feoB works differently or has an additional indi-
vidual mechanism in UTI or ABU strains.
Virulence factors may have distinctive and complex as-
sociations with one another.16 To identify these associa-
tions and the phenotypes of the present isolates, the
prevalence of profiles of the virulence genes was ascer-
tained. The fimHþkpsMTIIþfeoBþ profile was significantly
more prevalent in the ABU group (p < 0.01). This finding
might be due to a much larger discrepancy of feoB preva-
lence than fimH and kpsMTII between the two groups. In
addition, it could be possible that fimH and kpsMTII make
the UPEC strain more suitable for commensalism in the
human urinary tract when expressed with feoB.
Patients with UTI need early diagnosis and prompt
antibacterial treatment to minimize renal scarring and
progressive kidney damage. Empirical antibiotic treatment
is usually started in patients with suspected UTI. However,
antibiotic resistance has increased and is currently a major
problem in many countries.6,28 In this study, isolates from
ABU were found to be more resistant to most antimicrobials
tested, as shown in a previous study.15 It might be that long-
term exposure to various antimicrobials for ABU strains
induced antimicrobial resistances. By contrast, several
studies reported the relationship between antimicrobial
resistance and virulence factors of UPEC. Nalidixic acid
resistance has been associated with a lower prevalence of
sfa and a lower prevalence of pap, hly, and cnf1 has been
reported in fluoroquinolone-resistant strains than their
susceptible counterparts.35,36 Another study described that
all pap elements except for papG allele III, sfa/foc,kpsMTII, fyuA, and hlyA were associated with decreased
antibiotic resistance.16 In this study, tetracycline-resistant
strains more often harbored papEF and fyuA (p <0.05)
and feoB was associated with increased cefotaxime resis-
tance and tetracycline susceptibility (p <0.05). The pres-
ence and prevalence of virulence genes might depend on
the antibiotic’s mode of action or an unknown interaction
between virulence factors and antibiotics.
This study had several limitations. One was a relatively
small sample size, which requires further confirmation of
the findings. In addition, there was a possibility of
contamination of the urine samples derived from a urine
bag. Nevertheless, the possibility of selection bias might be
low because the inclusion criteria were strictly applied to
all participants. Finally, we could not match the UTI and
ABU groups for other conditions, such as host immunity,
socioeconomic status, and history of antibiotic use. Despite
these limitations, our study could be valuable for under-
standing molecular characteristics of UPEC, especially
strains isolated from Korean children. The findings support
the importance of some identified virulence genes as
important effectors in the development of symptomatic
UTI.
In conclusion, UPEC strains from Korean children with
UTI and ABU had different molecular epidemiologic fea-
tures concerning their major virulence genes. The papEF
and fyuA genes were implicated as important virulence
genes for development of UTI in children. Further in-
vestigations about feoB are needed to understand its sig-
nificance in UTI or ABU.Conflicts of interest
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